SALATAC

For adults, children and the elderly. Salatac Gel should be applied once daily. The gel should be applied once every night. Treatment can take up to twelve (12) weeks for resistant lesions to disappear, and it is necessary to persevere with the treatment.

1. Every night, soak the affected site in warm water for 2 to 3 minutes. 2. Dry thoroughly with the patient's own towel. 3. Carefully apply one or two drops of the gel to the lesion and allow to dry over its surface. Take care to avoid spreading on to surrounding normal skin.

No adhesive plaster is necessary. 4. The following evening, carefully remove and discard the elastic film formed from the previous application, and reapply the gel. Occasionally, if removal of the elastic film proves difficult, carefully reapply the gel directly over it and allow to dry.

This should help thicken the film to assist removal. If necessary, such re-application may be made on two or three successive days. 5. Once a week, gently rub away the treated surface using an emery board, as provided, or pumice stone used only for this purpose, before re-applying the gel.

6. The wart, verruca, corn or callus may take up to twelve (12) weeks to disappear and it is important to persevere with the treatment. 7. At the end of treatment, if the elastic film is difficult to remove, it may be allowed to remain on the skin until it sheds.

8. Avoid inhaling vapour, and keep cap firmly closed when not in use. Contact with clothing, fabrics, plastics and other materials may cause damage, and should be avoided. For external use only. Keep all medicines out of the reach of children.

5. Interactions with other medicinal products and other forms of interaction None known. 6 Fertility, pregnancy and lactation There are no or limited amount of data from the use of Salatac Gel during pregnancy. Salatac Gel should not be used during pregnancy, except for short-term treatment of a small single wart, verruca, corn or callus.

It is not known if the systemic Salatac Gel exposure reached after topical administration can be harmful to an embryo/fetus. During the third trimester of pregnancy, systemic use of prostaglandin synthetase inhibitors may induce cardiopulmonary and renal toxicity in the fetus.

At the end of the pregnancy prolonged bleeding time in both mother and child may occur, and labour can be delayed. 7. Effects on ability to drive and use machines None known. 8 Undesirable effects Salatac Gel may be irritant in certain patients, which in rare instances may appear as a temporary blemish on the skin.

4. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Keep away from the eyes, mucous membranes and from cuts and grazes. The gel should be applied carefully to the wart, verruca, corn or callus only, to avoid possible irritation of surrounding normal skin. Do not use excessively. Some mild, transient irritation may be expected, but in cases of more severe or persistent pain/irritation, the treatment should be suspended and/or discontinued.

8. Avoid inhaling vapour, and keep cap firmly closed when not in use. Contact with clothing, fabrics, plastics and other materials may cause damage, and should be avoided. For external use only. Keep all medicines out of the reach of children.

Not to be used on or near the face, intertriginous or anogenital regions, or by diabetics or individuals with impaired peripheral blood circulation. Not to be used on moles or on any other skin lesions for which the gel is not indicated.

Not to be used in cases of sensitivity to any of the ingredients.